BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36183642)

  • 1. Synthesis, characterization, antioxidant potential, and cytotoxicity screening of new Cu(II) complexes with 4-(arylchalcogenyl)-1H-pyrazoles ligands.
    Pinheiro AC; Busatto FF; Schaefer BT; Tomasini PP; Nunes IJ; Machado TDS; Cargnelutti R; de Aquino TFB; Ferreira KQ; Casaril AM; Jacob RG; Savegnago L; Hartwig D; Saffi J
    J Inorg Biochem; 2022 Dec; 237():112013. PubMed ID: 36183642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant and Anticancer Potential of the New Cu(II) Complexes Bearing Imine-Phenolate Ligands with Pendant Amine N-Donor Groups.
    Pinheiro AC; Nunes IJ; Ferreira WV; Tomasini PP; Trindade C; Martins CC; Wilhelm EA; Oliboni RDS; Netz PA; Stieler R; Casagrande OL; Saffi J
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antioxidant activity and toxicity of sulfur- or selenium-containing 4-(arylchalcogenyl)-1
    Hartwig de Oliveira D; Sousa FSS; Birmann PT; Pesarico AP; Alves D; Jacob RG; Savegnago L
    Can J Physiol Pharmacol; 2020 Jul; 98(7):441-448. PubMed ID: 32597688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, molecular structure and antioxidant activity of bis [L(μ
    Dos Santos TM; Martins CC; Bueno DT; Nunes IJ; Busatto FF; Cargnelutti R; Luchese C; de Lazaro Casagrande O; Saffi J; Wilhelm EA; Pinheiro AC
    J Inorg Biochem; 2020 Sep; 210():111130. PubMed ID: 32563104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
    Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
    J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfur donor atom effects on copper(I)/O(2) chemistry with thioanisole containing tetradentate N(3)S ligand leading to μ-1,2-peroxo-dicopper(II) species.
    Lee Y; Lee DH; Park GY; Lucas HR; Narducci Sarjeant AA; Kieber-Emmons MT; Vance MA; Milligan AE; Solomon EI; Karlin KD
    Inorg Chem; 2010 Oct; 49(19):8873-85. PubMed ID: 20822156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the antioxidant action of selenium and sulfur using Cu(I)-chalcogenone tris(pyrazolyl)methane and -borate complexes.
    Kimani MM; Brumaghim JL; VanDerveer D
    Inorg Chem; 2010 Oct; 49(20):9200-11. PubMed ID: 20836514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halo-substituted thiosemicarbazones and their copper(II), nickel(II) complexes: detailed spectroscopic characterization and study of antitumour activity against HepG2 human hepatoblastoma cells.
    Jagadeesh M; Kalangi SK; Sivarama Krishna L; Reddy AV
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():552-6. PubMed ID: 24084484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moiety.
    Massoud SS; Louka FR; Dial MT; Malek AJ; Fischer RC; Mautner FA; Vančo J; Malina T; Dvořák Z; Trávníček Z
    Dalton Trans; 2021 Sep; 50(33):11521-11534. PubMed ID: 34346447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper (II) complexes with N, S donor pyrazole-based ligands as anticancer agents.
    Ghorbanpour M; Soltani B; Mota A; Jahanbin Sardroodi J; Mehdizadeh Aghdam E; Shayanfar A; Molavi O; Mohammad-Rezaei R; Ebadi-Nahari M; Ziegler CJ
    Biometals; 2022 Oct; 35(5):1095-1111. PubMed ID: 36001216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity.
    Mutlu Gençkal H; Erkisa M; Alper P; Sahin S; Ulukaya E; Ari F
    J Biol Inorg Chem; 2020 Feb; 25(1):161-177. PubMed ID: 31832781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
    Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
    Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
    Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
    J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro DNA-Binding, Anti-Oxidant and Anticancer Activity of Indole-2-Carboxylic Acid Dinuclear Copper(II) Complexes.
    Wang X; Yan M; Wang Q; Wang H; Wang Z; Zhao J; Li J; Zhang Z
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrophosphate-mediated magnetic interactions in Cu(II) coordination complexes.
    Marino N; Ikotun OF; Julve M; Lloret F; Cano J; Doyle RP
    Inorg Chem; 2011 Jan; 50(1):378-89. PubMed ID: 21114311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activities of sulfamethoxazolyl-azo-phenols and their Cu(II) complexes along with molecular docking properties.
    Sahu N; Mondal S; Sepay N; Gupta S; Torres-Lopez E; Tanaka S; Akitsu T; Sinha C
    J Biol Inorg Chem; 2017 Aug; 22(6):833-850. PubMed ID: 28455542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective synthesis of oxime containing Pd(II) compounds: highly effective, selective and stereo-regulated cytotoxicity against carcinogenic PC-3 cells.
    de la Cueva-Alique I; de la Torre-Rubio E; Muñoz-Moreno L; Calvo-Jareño A; Pérez-Redondo A; Gude L; Cuenca T; Royo E
    Dalton Trans; 2022 Aug; 51(34):12812-12828. PubMed ID: 35796301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper(II) complexes with tridentate pyrazole-based ligands: synthesis, characterization, DNA cleavage activity and cytotoxicity.
    Gama S; Mendes F; Marques F; Santos IC; Carvalho MF; Correia I; Pessoa JC; Santos I; Paulo A
    J Inorg Biochem; 2011 May; 105(5):637-44. PubMed ID: 21450266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper(I)/O2 chemistry with imidazole containing tripodal tetradentate ligands leading to mu-1,2-peroxo-dicopper(II) species.
    Lee Y; Park GY; Lucas HR; Vajda PL; Kamaraj K; Vance MA; Milligan AE; Woertink JS; Siegler MA; Narducci Sarjeant AA; Zakharov LN; Rheingold AL; Solomon EI; Karlin KD
    Inorg Chem; 2009 Dec; 48(23):11297-309. PubMed ID: 19886646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands.
    Pellei M; Gandin V; Marchiò L; Marzano C; Bagnarelli L; Santini C
    Molecules; 2019 May; 24(9):. PubMed ID: 31067640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.